Maine Medicine Weekly Update - Maine Medicine Weekly Update
October 18, 2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
LEAD STORY
•  FDA Advisory Committee Recommends Moderna, J&J Boosters. What You Need to Know
More COVID Guidance & News
•  Maine CDC Memos: Planning Efforts for Moderna Booster and Pfizer Vaccine for 5-11-year-olds
•  Draft Study Shows Moderna & Pfizer May Be Better Boost for J&J Recipients
•  FDA Schedules Advisory Committee Meeting to Discuss COVID-19 Oral Treatment
•  Federal COVID Vaccine Mandate Rules Have Been Drafted
Maine Health System News
•  Central Maine Healthcare Services, Staffing, Vaccine Mandate, CEO Appointment
Clinical News
•  New Draft Recommendation Statement on Aspirin Use to Prevent Heart Disease and Stroke
•  Top JAMA, JAMA Network, and New England Journal of Medicine Articles
Physician Well Being
•  Using Electronic Health Records to Predict Physician Departure
Webinars
•  Preventing Stimulant Misuse Among College-Aged Students
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
•  SUPPORT for ME Training and Technical Assistance Initiative
•  SUPPORT For ME Training and Technical Assistance Initiative Webinars on November 3 & December 1
•  Maine Independent Clinical Information Service: MICIS presentations & Academic Detailing
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Physician (BC/BE in Family Medicine) - Mt. Abram Regional Health Center, (Kingfield, Maine)
•  Physician (BC/BE in Family Medicine) - Bingham Area Health Center

 

Draft Study Shows Moderna & Pfizer May Be Better Boost for J&J Recipients

A new National Institutes of Health (NIH) study suggested Moderna's or Pfizer's vaccine also work as a booster for J&J recipients and may benefit more from getting a Pfizer or Moderna vaccine as their booster instead of another J&J shot. The study is preliminary and hasn't been peer reviewed.

People who received an mRNA-based booster vaccination had a four-fold increase in their neutralization response more frequently than those who were boosted with J&J's adenovirus vaccine.

A new National Institutes of Health (NIH) study suggested Moderna's or Pfizer's vaccine also work as a booster for J&J recipients and may benefit more from getting a Pfizer or Moderna vaccine as their booster instead of another J&J shot. The study is preliminary and hasn't been peer reviewed.

People who received an mRNA-based booster vaccination had a four-fold increase in their neutralization response more frequently than those who were boosted with J&J's adenovirus vaccine.

During the Friday meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), a top FDA official told the committee that the agency might consider allowing Johnson & Johnson recipients to receive a booster shot of the Moderna or Pfizer-BioNTech vaccines but gave no timetable for that decision.

Click here for NPR story on NIH study: NIH study of COVID-19 vaccine boosters suggests Moderna or Pfizer works best

Click here for a draft of the NIH study: Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report